Maravai Q2 FY26 net loss narrows to $21.6 million; revenue rises 8.5% to $51.4 million - MRVI News | RalliesMaravai Q2 FY26 net loss narrows to $21.6 million; revenue rises 8.5% to $51.4 million
M
MRVI• Operations and guidance
- Opened a GMP enzyme manufacturing facility, expanding TriLink’s integrated IVT raw materials offering.
- Raised full-year adjusted EBITDA (non-GAAP) guidance to $33 million-$35 million, reiterating revenue outlook of $205 million-$215 million.
Q2 results and segment performance
- Maravai posted second-quarter revenue up 8.5% to $51.44 million, while GAAP net loss narrowed to $21.63 million.
- Adjusted EBITDA (non-GAAP) swung to a profit of $8.67 million from a loss a year earlier.
- TriLink revenue rose 11.5% to $34.67 million; Cygnus increased 2.8% to $16.77 million.
•
